Stock listing
Fulcrum Therapeutics, Inc.
- Ticker
- NASDAQ:FULC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. is a public company traded under the ticker FULC on the American market. Fulcrum focuses on developing innovative therapies for patients with genetically driven diseases.
Latest news from Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Fulcrum Therapeutics, Inc. - FULC
Aug 19, 2026
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Aug 17, 2026
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
Jun 1, 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
Apr 27, 2026